The Pennant Group, Inc.
General ticker "PNTG" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $780.4M (TTM average)
The Pennant Group, Inc. follows the US Stock Market performance with the rate: 27.3%.
Estimated limits based on current volatility of 1.5%: low 29.70$, high 30.61$
Factors to consider:
- Total employees count: 7000 (+20.9%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Medicare reimbursement changes, Staffing challenges, Payor cost control, Acquisition/divestiture risks, Regulatory and compliance
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [22.68$, 35.68$]
- 2026-12-31 to 2027-12-31 estimated range: [23.47$, 37.03$]
Financial Metrics affecting the PNTG estimates:
- Positive: with PPE of 24.7 at the end of fiscal year the price was neutral
- Positive: -4.75 < Operating profit margin, % of 5.42
- Negative: 0 < Inventory ratio change, % of 0.33
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.37
- Positive: -9.07 < Industry operating profit margin (median), % of 0.88
- Negative: Operating cash flow per share per price, % of 4.80 <= 6.64
- Positive: 5.46 < Industry operating cash flow per share per price (median), % of 5.67
- Negative: 0.01 < Interest expense per share per price, % of 0.66
- Negative: Investing cash flow per share per price, % of -22.64 <= -14.22
- Negative: -0.16 < Industry inventory ratio change (median), % of 0
Short-term PNTG quotes
Long-term PNTG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $544.89MM | $695.24MM | $947.71MM |
| Operating Expenses | $519.72MM | $657.12MM | $896.32MM |
| Operating Income | $25.17MM | $38.12MM | $51.39MM |
| Non-Operating Income | $-5.58MM | $-6.75MM | $-5.76MM |
| Interest Expense | $5.92MM | $6.96MM | $6.68MM |
| Income(Loss) | $19.58MM | $31.37MM | $45.63MM |
| Taxes | $5.67MM | $7.03MM | $11.87MM |
| Profit(Loss)* | $13.38MM | $22.56MM | $29.58MM |
| Stockholders Equity | $145.51MM | $311.96MM | $332.60MM |
| Assets | $539.69MM | $679.52MM | $968.18MM |
| Operating Cash Flow | $33.09MM | $39.30MM | $48.29MM |
| Capital expenditure | $8.11MM | $8.99MM | $22.00MM |
| Investing Cash Flow | $-30.22MM | $-70.68MM | $-227.97MM |
| Financing Cash Flow | $1.11MM | $49.57MM | $172.46MM |
| Earnings Per Share** | $0.45 | $0.72 | $0.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.